medsovetМедицинский СоветMeditsinskiy sovet = Medical Council2079-701X2658-5790REMEDIUM GROUP Ltd.10.21518/2079-701X-2014-11-60-61medsovet-670Research ArticleНЕВРОЛОГИЯNEUROLOGYАлгоритм терапии расстройств сна у пациентов с когнитивными нарушениямиAlgorithm for the treatment of sleep disorders in patients with cognitive impairmentПреображенскаяИ. С.PreobrazhenskayaI. S.noemail@neicon.ruПервый Московский государственный медицинский университет им. И.М. СеченоваРоссияClinic of Nervous Diseases of the First Moscow State Medical University named after I.M. SechenovRussian Federation2014301220140116061Copyright © Преображенская И.С., 20142014Преображенская И.С.Preobrazhenskaya I.S.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.med-sovet.pro/jour/article/view/670

Отдельные когнитивные симптомы, которые не вызывают затруднений в повседневной жизни, в т. ч. и в наиболее сложных формах профессиональной и социально-бытовой активности, но тем не менее могут вызвать субъективное беспокойство и представляют собой снижение когнитивных способностей по сравнению с индивидуальной нормой

Algorithm for the treatment of sleep disorders in patients with cognitive impairment

ЛКНтип когнитивных нарушенийУКНReferencesWaldhauser F, Weiszenbacher G, Tatzer E et al. Alterations in nocturnal serum melatonin levels in humans with growth and aging. J. Clin. Endocrinol Metab., 1988, 66(3): 648-652.Waldhauser F, Weiszenbacher G, Tatzer E et al. Alterations in nocturnal serum melatonin levels in humans with growth and aging. J. Clin. Endocrinol Metab., 1988, 66(3): 648-652.Sharma M, Palacios-Bois J, Schwartz G et al. Circadian rhythms of melatonin and cortisol in aging. Biol. Psychiatry, 1989,25(3): 305-319.Sharma M, Palacios-Bois J, Schwartz G et al. Circadian rhythms of melatonin and cortisol in aging. Biol. Psychiatry, 1989,25(3): 305-319.Circadin: European Medicines Agency Public Assessment Reports for Circadin. URLwww.emea. europa.eu/ humandocs/Humans/EPAR/circadin/circadin.htm Accessed 2012.Circadin: European Medicines Agency Public Assessment Reports for Circadin. URLwww.emea. europa.eu/ humandocs/Humans/EPAR/circadin/circadin.htm Accessed 2012.European Medicines Agency. Circadin: Product Information (SPC). URL:www. Ema.europa.eu/docs/en_GB/ document_library/EPAR-Product_Information/human000695/WC500026811.pdf Accessed 2012.European Medicines Agency. Circadin: Product Information (SPC). URL:www. Ema.europa.eu/docs/en_GB/ document_library/EPAR-Product_Information/human000695/WC500026811.pdf Accessed 2012.Luthringer R, Muzet M, Zisapel N, Staner L. The effect of prolonged-release melatonin on sleep measures and psychomotor performance in eldery patients with insomnia. Int Clin. Psychopharmacol., 2009, 24(5): 239-249.Luthringer R, Muzet M, Zisapel N, Staner L. The effect of prolonged-release melatonin on sleep measures and psychomotor performance in eldery patients with insomnia. Int Clin. Psychopharmacol., 2009, 24(5): 239-249.Lemoine P, Garfinkel D, Laudon M et al. Prolonged release melatonin for insomnia: an open label long term study of efficacy, safety and withdrawal. Ther. Clin. Risk. Manag., 2011, 7: 301-311.Lemoine P, Garfinkel D, Laudon M et al. Prolonged release melatonin for insomnia: an open label long term study of efficacy, safety and withdrawal. Ther. Clin. Risk. Manag., 2011, 7: 301-311.Lemoine P, Nir T, Laudon M, Zisapel N. Prolonged-release melatonin improves sleep quality and morning alertness in insomnia patients aged 55 years and older and has no withdrawal effects. J. Sleep. Res., 2007, 16(4): 372-380.Lemoine P, Nir T, Laudon M, Zisapel N. Prolonged-release melatonin improves sleep quality and morning alertness in insomnia patients aged 55 years and older and has no withdrawal effects. J. Sleep. Res., 2007, 16(4): 372-380.Wade AG, Ford I, Crawford G et al. Efficacy of prolonged-release melatonin in insomnia patients aged 55-80 years: quality of sleep and next-day alertness outcomes. Curr.Med. Res. Opin., 2007, 23(10): 2597-2605.Wade AG, Ford I, Crawford G et al. Efficacy of prolonged-release melatonin in insomnia patients aged 55-80 years: quality of sleep and next-day alertness outcomes. Curr.Med. Res. Opin., 2007, 23(10): 2597-2605.

The authors declare that there are no conflicts of interest present.